Art. 54 Directive (EU) 2001/83

In forcesince 21 Jul 2011cited 32×

The following particulars shall appear on the outer packaging of medicinal products or, where there is no outer packaging, on the immediate packaging:

(a)

the name of the medicinal product followed by its strength and pharmaceutical form, and, if appropriate, whether it is intended for babies, children or adults; where the product contains up to three active substances, the international non-proprietary name (INN) shall be included, or, if one does not exist, the common name;

(b)

a statement of the active substances expressed qualitatively and quantitatively per dosage unit or according to the form of administration for a given volume or weight, using their common names;

(c)

the pharmaceutical form and the contents by weight, by volume or by number of doses of the product;

(d)

a list of those excipients known to have a recognized action or effect and included in the detailed guidance published pursuant to Article 65. However, if the product is injectable, or a topical or eye preparation, all excipients must be stated;

(e)

the method of administration and, if necessary, the route of administration. Space shall be provided for the prescribed dose to be indicated;

(f)

a special warning that the medicinal product must be stored out of the reach and sight of children;

(g)

a special warning, if this is necessary for the medicinal product;

(h)

the expiry date in clear terms (month/year);

(i)

special storage precautions, if any;

(j)

specific precautions relating to the disposal of unused medicinal products or waste derived from medicinal products, where appropriate, as well as reference to any appropriate collection system in place;

(k)

the name and address of the marketing authorisation holder and, where applicable, the name of the representative appointed by the holder to represent him;

(l)

the number of the authorization for placing the medicinal product on the market;

(m)

the manufacturer's batch number;

(n)

in the case of non-prescription medicinal products, instructions for use;

(o)

for medicinal products other than radiopharmaceuticals referred to in Article 54a(1), safety features enabling wholesale distributors and persons authorised or entitled to supply medicinal products to the public to:

verify the authenticity of the medicinal product, and

identify individual packs,

as well as a device allowing verification of whether the outer packaging has been tampered with.

The 10 that are cited most themselves, of 32.

  • Regulation (EU) 2016/16143Law

    … да са с нанесени показатели за безопасност в съответствие с член 54, буква о) от Директива 2001/83/ЕО и настоящия регламент; б) …

  • Directive (EU) 2011/6234Law

    … Evalueringen skal navnlig vurdere artikel 54, litra o), og artikel 54a i direktiv 2001/83/EF som indsat ved nærværende direktiv.

  • Judgment of the Court (Third Chamber) of 5 May 2011. MSD Sharp & Dohme GmbH v Merckle GmbH.Decision

    In that connection, it should be observed that Article 61 of Directive 2001/83 provides that all the information appearing on the packaging and the package leaflet of a medicinal product must have been submitted to the competent …

    5 May 2011 · 62009CJ0316

  • BGH, Urteil vom 5. Februar 2009 - I ZR 124/07Decision

    Der Senat hat in der Entscheidung "Amlodipin" unter Heranziehung der Art. 54 und 62 der Richtlinie 2001/83/EG des Europäischen Parlaments und des Rates vom 6. November 2001 zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel …

    5 Feb 2009 · I_ZR_124-07

  • Opinion of Advocate General Szpunar delivered on 13 January 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    In fact, in so far as the applicable legislation requires that medicinal products display certain information, both on the packaging and in a packet leaflet normally contained inside the packaging, which must be in the official language or …

    13 Jan 2022 · 62020CC0147

  • Regulation (EU) 2021/457Law

    … 67.], en met name artikel 54 bis, lid 2, onder d), Overwegende hetgeen volgt:

  • Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 Novembe…11Law

    Чрез дерогация от разпоредбите на член 54 и член 55, параграф 1 от Директива 2001/83/ЕО изброените в приложение III към настоящия …

  • Regeling Geneesmiddelenwet2.3a4a.3Law

    … waarmee de identiteit en authenticiteit van afzonderlijke verpakkingen kan worden vastgesteld, bedoeld in artikel 54, onder o, van richtlijn 2001/83, als die geneesmiddelen worden afgeleverd aan: a. een arts, instelling of organisatie als …

  • BGH, Urteil vom 30. März 2017 - I ZR 263/15Decision

    … Die Bestimmung des Art. 55 Abs. 1 der Richtlinie 2001/83/EG ordnet grundsätzlich an, dass Primärverpackungen die in Art. 54 der Richtlinie 2001/83/EG genannten Angaben aufweisen müssen. Art. 55 Abs. 2 und 3 der Richtlinie 2001/83/EG …

    30 Mar 2017 · KORE318682017

  • Regulation (EU) 2023/11823Law

    … Показателите за безопасност, посочени в член 54, буква о) от Директива 2001/83/ЕО, не се поставят върху външната опаковка или, когато …